Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
What's an atmospheric river? AP explains the weather phenomenon - 2It's official: NASA's Artemis 2 moon mission will break humanity's all-time distance record
- 3Climate change is straining Alaska's Arctic. A new mining road may push the region past the brink
- 4Revealing the Specialty of Food Matching: Improving Culinary Encounters
- 5Jupiter and the moon take a sunset stroll on March 26. Here's how to see it
- Oldest evidence of human fire-making discovered at site in England
- Germany's far-right AfD tops poll ahead of Merz's conservatives
- EU chief urges Iran to free imprisoned protesters, lift internet ban
- Two Israeli infants among wounded by shrapnel in overnight Iranian missile barrage
- Step by step instructions to Pick A Pre-owned vehicle Stage
- Melodic Combination d: A Survey of \Unrecorded Music Energy\ Show
- Savvy Cleaning: The 6 Robot Vacuums of 2024
- Like many holiday traditions, lighting candles and fireplaces is best done in moderation
- I visited every country by 25. Antarctica showed me how much I still hadn't seen.
